Wisdom Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBRUTINIB, with a corresponding US DMF Number 38919.
Remarkably, this DMF maintains an Active status since its submission on September 26, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 31, 2024, and payment made on September 28, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II